Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation
British Journal of Cancer (2004) - Comments
pubmed: 15494718  doi: 10.1038/sj.bjc.6602190  issn: 0007-0920  issn: 1532-1827 

E Deutsch, L Maggiorella, B Wen, M L Bonnet, K Khanfir, V Frascogna, A G Turhan, J Bourhis